We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$14.6B
AUM Growth
-$1.84B
Cap. Flow
-$1.86B
Cap. Flow %
-12.78%
Top 10 Hldgs %
34.48%
Holding
2,201
New
633
Increased
437
Reduced
361
Closed
764

Top Buys

Rank Stock Value
1
DUK icon
Duke Energy
DUK
+$172M
2
CVX icon
Chevron
CVX
+$99.4M
3
AAPL icon
Apple
AAPL
+$91.7M
4
EVRG icon
Evergy
EVRG
+$89M
5
ED icon
Consolidated Edison
ED
+$86.6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$412M
2
MDLZ icon
Mondelez International
MDLZ
+$131M
3
JNJ icon
Johnson & Johnson
JNJ
+$107M
4
NI icon
NiSource
NI
+$88.5M
5
PPL
PPL Corp
PPL
+$86.4M

Sector Composition

Rank Sector Weight
1 Financials 9.81%
2 Technology 9.77%
3 Healthcare 7.98%
4 Utilities 7.37%
5 Real Estate 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBWM icon
1826
Mercantile Bank Corp
MBWM
$1.03B
-6,426
Closed -$281K
MCO icon
1827
Moody's
MCO
$87.2B
-41,483
Closed -$19.7M
MCS icon
1828
Marcus Corp
MCS
$912M
-40,946
Closed -$617K
MCY icon
1829
Mercury Insurance
MCY
$5.85B
-14,036
Closed -$884K
MDGL icon
1830
Madrigal Pharmaceuticals
MDGL
$11.9B
-2,645
Closed -$561K
MDLZ icon
1831
Mondelez International
MDLZ
$82.3B
-1,784,906
Closed -$131M
MEI icon
1832
Methode Electronics
MEI
$507M
-63,989
Closed -$765K
MELI icon
1833
Mercado Libre
MELI
$97.5B
-3,302
Closed -$6.78M
MERC icon
1834
Mercer International
MERC
$28.5M
-63,907
Closed -$433K
MET icon
1835
MetLife
MET
$60B
-31,115
Closed -$2.57M
MFIN icon
1836
Medallion Financial
MFIN
$268M
-26,357
Closed -$215K
MG icon
1837
Mistras Group
MG
$604M
-16,468
Closed -$187K
MHK icon
1838
Mohawk Industries
MHK
$9.23B
-35,006
Closed -$5.63M
MKTW icon
1839
MarketWise
MKTW
$50.6M
-1,254
Closed -$17K
MLR icon
1840
Miller Industries
MLR
$649M
-4,004
Closed -$244K
MLTX icon
1841
MoonLake Immunotherapeutics
MLTX
$1.34B
-16,855
Closed -$850K
MMM icon
1842
CALL
3M
MMM
$92.3B
-5,400
Closed -$738K
MMM icon
1843
PUT
3M
MMM
$92.3B
-1,300
Closed -$178K
MMSI icon
1844
Merit Medical Systems
MMSI
$5.42B
-182,949
Closed -$18.1M
MOS icon
1845
The Mosaic Company
MOS
$7.76B
-90,169
Closed -$2.42M
MPWR icon
1846
Monolithic Power Systems
MPWR
$64.7B
-13,904
Closed -$12.9M
MRC
1847
DELISTED
MRC Global
MRC
-25,112
Closed -$320K
MRCY icon
1848
Mercury Systems
MRCY
$5.49B
-51,963
Closed -$1.92M
MRTN icon
1849
Marten Transport
MRTN
$1.22B
-166,249
Closed -$2.94M
MRUS
1850
DELISTED
Merus
MRUS
-264,068
Closed -$13.2M

Similar funds

Michael Gelband's Q4 2024 Portfolio in Review

As of Q4 2024, Michael Gelband held 2,201 positions worth $14.6B, down 11% from $16.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband withdrew a net $1.86B in Q4 2024, closing 764 positions and reducing 361 holdings. Its most notable exit was Mondelez International, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.8% of assets, up from 4.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Michael Gelband opened a new position in Duke Energy worth $164M.

  • Michael Gelband's largest Q4 2024 buy was Duke Energy: 1,520,504 shares worth $164M.
  • Michael Gelband added most to Chevron in Q4 2024, an estimated $99.4M increase.
  • Michael Gelband's biggest Q4 2024 reduction was Microsoft, cutting an estimated $412M.
  • Michael Gelband fully exited Mondelez International in Q4 2024, selling an estimated $131M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.6B portfolio in Q4 2024.
  • Michael Gelband opened 633 new positions and closed 764 in Q4 2024.
  • Michael Gelband's portfolio value fell 11% quarter-over-quarter to $14.6B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.